Evaluation of Drug-Related Problems and Pharmacist Interventions in Hospitalized Patients: A Prospective Observational Study
TL;DR
Elderly inpatients with polypharmacy and cardiovascular comorbidities represent the highest risk group for preventable DRPs, and proactive clinical pharmacist integration through daily ward rounds and medication reconciliation achieves a high rate of problem resolution, enhancing inpatient drug safety.
Abstract
Background: Drug-related problems (DRPs) pose critical challenges in acute inpatient care, significantly undermining therapeutic efficacy, increasing patient safety hazards, and escalating healthcare expenditures.Objective: To evaluate the incidence, nature, underlying causes, and clinical outcomes of DRPs in hospitalized inpatients, alongside assessing the impact of clinical pharmacist-led interventions in a tertiary care setting. Setting: Inpatient Department (IPD) of Shivapuje Heart Care Hospital, Latur, Maharashtra, India over a 6-month prospective study period (2024–2025). Method: A prospective observational study enrolled 100 adult hospitalized inpatients (length of stay ≥24 hours) using consecutive sampling. Daily medication chart reviews, laboratory tracking, and direct clinical monitoring were conducted. Identified DRPs were systematically categorized according to the Pharmaceutical Care Network Europe (PCNE V9.1) classification framework. Interventions were offered at prescriber and drug levels, and clinical resolution was tracked until discharge. Main outcome measure: Incidence and nature of DRPs (PCNE V9.1 Problem, Cause, Intervention, and Outcome domains), proportion of manifest vs. potential problems, high-risk drug classes, and overall pharmacist-mediated clinical resolution rate (Outcome c + d). Results: Among 100 enrolled inpatients (53% male; peak age 69–81 years at 28%), hypertension (58%) and diabetes mellitus (52%) were the primary comorbidities. Overall, 57% of identified DRPs were manifest problems (actual clinical harm), while 43% were potential problems. Under PCNE V9.1 domains, Adverse Drug Reactions (P2) comprised 72.7% of categorized issues, dominated by non-allergic events (51.51%). Etiological assessment of 154 cause codes identified Dose Selection errors (C3) as the primary cause, where excessive dosing (C3.b) represented 80.5% of dose errors. Inappropriate drug selection (C1.a) and combination (C1.b) accounted for 22.07% and 18.18% of causes, respectively. High-risk drug classes implicated included antiplatelets/anticoagulants (20%), antibiotics (19%), and diuretics (12%). Clinical pharmacist interventions led to drug cessation in 76.38% of drug-level actions and therapy modifications in 24.08% of prescriber actions. Overall, 38% of DRPs were completely resolved and 36% were partially resolved, achieving a 74% positive clinical resolution rate. Conclusion: Elderly inpatients with polypharmacy and cardiovascular comorbidities represent the highest risk group for preventable DRPs. Proactive clinical pharmacist integration through daily ward rounds and medication reconciliation achieves a high rate of problem resolution, enhancing inpatient drug safety.